암 세포의 증식억제활성을 갖는2′,4′,5,7-테트라하이드록시-5′,6-디프레닐 플라바논화합물을 함유하는 암 예방 및 치료를 위한 조성물
    2.
    发明公开
    암 세포의 증식억제활성을 갖는2′,4′,5,7-테트라하이드록시-5′,6-디프레닐 플라바논화합물을 함유하는 암 예방 및 치료를 위한 조성물 有权
    包含2',4',5,7-四氢叶酸-5',6-二苯基甲酰胺化合物的组合物显示抑制肿瘤细胞传播活性以预防和治疗癌症疾病

    公开(公告)号:KR1020070083237A

    公开(公告)日:2007-08-23

    申请号:KR1020070081393

    申请日:2007-08-13

    Abstract: A pharmaceutical composition containing 2,4,5,7-tetrahydroxy-5,6-diprenyl flavanone compound extracted from root of Cudrania tricuspidata is provided to inhibit propagation of tumor cells due to kinase 2(CKII) inhibition effect, thereby being used as a pharmaceutical composition for preventing and treating cancer diseases. The pharmaceutical composition for preventing and treating cancer diseases comprises 2,4,5,7-tetrahydroxy-5,6-diprenyl flavanone compound having tumor cell propagation inhibiting activity and represented by the formula(1) or a pharmaceutically acceptable salt thereof as an effective ingredient.

    Abstract translation: 提供含有从三头from根提取的2,4,5,7-四羟基-5,6-二肾上腺黄烷酮化合物的药物组合物,以抑制由于激酶2(CKII)抑制作用而导致的肿瘤细胞增殖,从而被用作 用于预防和治疗癌症疾病的药物组合物。 用于预防和治疗癌症疾病的药物组合物包含具有肿瘤细胞增殖抑制活性并由式(1)表示的2,4,5,7-四羟基-5,6-二肾上腺黄烷酮化合物或其药学上可接受的盐作为有效的 成分。

Patent Agency Ranking